Literature DB >> 19955178

Transforming growth factor beta-activated kinase 1 (TAK1) kinase adaptor, TAK1-binding protein 2, plays dual roles in TAK1 signaling by recruiting both an activator and an inhibitor of TAK1 kinase in tumor necrosis factor signaling pathway.

Peter Broglie1, Kunihiro Matsumoto, Shizuo Akira, David L Brautigan, Jun Ninomiya-Tsuji.   

Abstract

Transforming growth factor beta-activated kinase 1 (TAK1) kinase is an indispensable signaling intermediate in tumor necrosis factor (TNF), interleukin 1, and Toll-like receptor signaling pathways. TAK1-binding protein 2 (TAB2) and its closely related protein, TAB3, are binding partners of TAK1 and have previously been identified as adaptors of TAK1 that recruit TAK1 to a TNF receptor signaling complex. TAB2 and TAB3 redundantly mediate activation of TAK1. In this study, we investigated the role of TAB2 by analyzing fibroblasts having targeted deletion of the tab2 gene. In TAB2-deficient fibroblasts, TAK1 was associated with TAB3 and was activated following TNF stimulation. However, TAB2-deficient fibroblasts displayed a significantly prolonged activation of TAK1 compared with wild type control cells. This suggests that TAB2 mediates deactivation of TAK1. We found that a TAK1-negative regulator, protein phosphatase 6 (PP6), was recruited to the TAK1 complex in wild type but not in TAB2-deficient fibroblasts. Furthermore, we demonstrated that both PP6 and TAB2 interacted with the polyubiquitin chains and this interaction mediated the assembly with TAK1. Our results indicate that TAB2 not only activates TAK1 but also plays an essential role in the deactivation of TAK1 by recruiting PP6 through a polyubiquitin chain-dependent mechanism.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19955178      PMCID: PMC2807291          DOI: 10.1074/jbc.M109.090522

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  Essential function for the kinase TAK1 in innate and adaptive immune responses.

Authors:  Shintaro Sato; Hideki Sanjo; Kiyoshi Takeda; Jun Ninomiya-Tsuji; Masahiro Yamamoto; Taro Kawai; Kunihiro Matsumoto; Osamu Takeuchi; Shizuo Akira
Journal:  Nat Immunol       Date:  2005-09-25       Impact factor: 25.606

2.  TAK1-binding protein 2 facilitates ubiquitination of TRAF6 and assembly of TRAF6 with IKK in the IL-1 signaling pathway.

Authors:  Satoshi Kishida; Hideki Sanjo; Shizuo Akira; Kunihiro Matsumoto; Jun Ninomiya-Tsuji
Journal:  Genes Cells       Date:  2005-05       Impact factor: 1.891

3.  Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases.

Authors:  Hideaki Kamata; Shi-Ichi Honda; Shin Maeda; Lufen Chang; Hajime Hirata; Michael Karin
Journal:  Cell       Date:  2005-03-11       Impact factor: 41.582

4.  Protein phosphatase 6 subunit with conserved Sit4-associated protein domain targets IkappaBepsilon.

Authors:  Bjarki Stefansson; David L Brautigan
Journal:  J Biol Chem       Date:  2006-06-12       Impact factor: 5.157

5.  Ferritin heavy chain upregulation by NF-kappaB inhibits TNFalpha-induced apoptosis by suppressing reactive oxygen species.

Authors:  Can G Pham; Concetta Bubici; Francesca Zazzeroni; Salvatore Papa; Joy Jones; Kellean Alvarez; Shanthi Jayawardena; Enrico De Smaele; Rong Cong; Carole Beaumont; Frank M Torti; Suzy V Torti; Guido Franzoso
Journal:  Cell       Date:  2004-11-12       Impact factor: 41.582

6.  TAK1 is a master regulator of epidermal homeostasis involving skin inflammation and apoptosis.

Authors:  Emily Omori; Kunihiro Matsumoto; Hideki Sanjo; Shintaro Sato; Shizuo Akira; Robert C Smart; Jun Ninomiya-Tsuji
Journal:  J Biol Chem       Date:  2006-05-04       Impact factor: 5.157

7.  TAK1 is a component of the Epstein-Barr virus LMP1 complex and is essential for activation of JNK but not of NF-kappaB.

Authors:  Noriyuki Uemura; Taisuke Kajino; Hideki Sanjo; Shintaro Sato; Shizuo Akira; Kunihiro Matsumoto; Jun Ninomiya-Tsuji
Journal:  J Biol Chem       Date:  2006-01-30       Impact factor: 5.157

8.  TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo.

Authors:  Jae-Hyuck Shim; Changchun Xiao; Amber E Paschal; Shannon T Bailey; Ping Rao; Matthew S Hayden; Ki-Young Lee; Crystal Bussey; Michael Steckel; Nobuyuki Tanaka; Gen Yamada; Shizuo Akira; Kunihiro Matsumoto; Sankar Ghosh
Journal:  Genes Dev       Date:  2005-10-31       Impact factor: 11.361

9.  JNK potentiates TNF-stimulated necrosis by increasing the production of cytotoxic reactive oxygen species.

Authors:  Juan-Jose Ventura; Patricia Cogswell; Richard A Flavell; Albert S Baldwin; Roger J Davis
Journal:  Genes Dev       Date:  2004-11-15       Impact factor: 11.361

10.  Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO.

Authors:  Chee-Kwee Ea; Li Deng; Zong-Ping Xia; Gabriel Pineda; Zhijian J Chen
Journal:  Mol Cell       Date:  2006-04-06       Impact factor: 17.970

View more
  32 in total

Review 1.  Novel Ser/Thr protein phosphatases in cell death regulation.

Authors:  Haipeng Sun; Yibin Wang
Journal:  Physiology (Bethesda)       Date:  2012-02

2.  Adaptation of HepG2 cells to a steady-state reduction in the content of protein phosphatase 6 (PP6) catalytic subunit.

Authors:  Joan M Boylan; Arthur R Salomon; Umadevi Tantravahi; Philip A Gruppuso
Journal:  Exp Cell Res       Date:  2015-05-18       Impact factor: 3.905

Review 3.  TAK1 control of cell death.

Authors:  S R Mihaly; J Ninomiya-Tsuji; S Morioka
Journal:  Cell Death Differ       Date:  2014-08-22       Impact factor: 15.828

Review 4.  TAK1 regulates hepatic cell survival and carcinogenesis.

Authors:  Yoon Seok Roh; Jingyi Song; Ekihiro Seki
Journal:  J Gastroenterol       Date:  2014-01-21       Impact factor: 7.527

Review 5.  TNFα in myocardial ischemia/reperfusion, remodeling and heart failure.

Authors:  Petra Kleinbongard; Rainer Schulz; Gerd Heusch
Journal:  Heart Fail Rev       Date:  2011-01       Impact factor: 4.214

6.  A novel MAP3K7 splice mutation causes cardiospondylocarpofacial syndrome with features of hereditary connective tissue disorder.

Authors:  Silvia Morlino; Marco Castori; Chiara Dordoni; Valeria Cinquina; Graziano Santoro; Paola Grammatico; Marina Venturini; Marina Colombi; Marco Ritelli
Journal:  Eur J Hum Genet       Date:  2018-02-21       Impact factor: 4.246

7.  Fas-associated death domain (FADD) is a negative regulator of T-cell receptor-mediated necroptosis.

Authors:  Stephanie L Osborn; Gretchen Diehl; Seong-Ji Han; Ling Xue; Nadia Kurd; Kristina Hsieh; Dragana Cado; Ellen A Robey; Astar Winoto
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-06       Impact factor: 11.205

8.  The TGFβ1 pathway is required for NFκB dependent gene expression in mouse keratinocytes.

Authors:  Kelly A Hogan; Anand Ravindran; Michael A Podolsky; Adam B Glick
Journal:  Cytokine       Date:  2013-09-24       Impact factor: 3.861

9.  Epithelial transforming growth factor β-activated kinase 1 (TAK1) is activated through two independent mechanisms and regulates reactive oxygen species.

Authors:  Emily Omori; Maiko Inagaki; Yuji Mishina; Kunihiro Matsumoto; Jun Ninomiya-Tsuji
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-13       Impact factor: 11.205

Review 10.  TGF-β signaling via TAK1 pathway: role in kidney fibrosis.

Authors:  Mary E Choi; Yan Ding; Sung Il Kim
Journal:  Semin Nephrol       Date:  2012-05       Impact factor: 5.299

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.